On a crowded train, some passengers ride in silence while others push toward the exit, shoving their neighbors aside. In every person's blood, mutant cells appear with age, and their fate is much the same: most changes are neutral, like passengers who are simply along for the ride, but some give a cell an edge, and it starts dividing faster than the rest. This expansion is called clonal hematopoiesis, and it raises the risk of blood cancer and heart disease. Scientists used to hunt for specific 'driver' mutations that push a cell forward, but the new study took a different route: it counted all the 'passengers,' the neutral mutations that simply pile up with each division.
To do this, the team took whole blood genomes from 791,067 people in two large biobanks: the British UK Biobank and the American All of Us. Instead of looking for known drivers, they measured the total burden of passenger mutations, single changes found in just one person and almost certainly irrelevant to a cell's survival. To filter out technical noise, they kept only variants supported by 4-8 reads out of 30x coverage, which corresponds to a clone making up a quarter or half of the blood cells. Then they removed the influence of age, sex, and smoking to get a quantitative trait: how heavily a person's blood is 'littered' with neutral mutations.
Comparing this trait against millions of genetic variants, the authors found 81 regions of the genome linked to mutation burden. 39 of them were already known from earlier clonal hematopoiesis studies, including the genes TERT, TCL1A, ATM, CHEK2, and BCL2. But 42 were new: among them NFE2, the master transcription factor for red blood cell and platelet maturation; MSANTD2, a regulator of stem cell adhesion; PTPN7, a phosphatase in the MAPK signaling pathway; and CD163, a macrophage receptor tied to anti-inflammatory polarization. A separate analysis of rare variants turned up 11 candidate genes, and the standout was MBD2, a protein that reads methyl marks on DNA. Harmful variants in this 'reader' raised mutation burden as strongly as somatic mutations in the 'writer' DNMT3A or the 'eraser' TET2.
Splitting participants by sex, the authors found 14 new loci, including RMND5B in women and OLIG3 in men. An analysis by ancestry in All of Us revealed an African locus, KAZN/TMEM51, and an East Asian locus, PTPRN2, with a particularly large effect. The observed mutation burden was more strongly associated with hematologic malignancies and mortality than a polygenic risk score calculated from known variants. Spatial analysis uncovered geographic clustering: in some regions the mutation burden is higher than in others, and income, air quality, or chemotherapy do not explain it. Some unmeasured environmental exposure seems to be at play.
Now it is clear why some people accumulate clones faster than others: inherited variants in dozens of genes govern the very process of neutral mutation buildup. Instead of hunting for drivers, the researchers measured the total passenger load, and that let them find more loci with a smaller sample size than previous studies. Even today, this burden can be folded into risk stratification models for acute myeloid leukemia and other age-related diseases. And the geographic puzzle is a reminder: the train of clonal expansion runs on tracks we cannot yet all see.
The MBD2 gene identified in this work encodes a protein that reads methylation marks on DNA. If DNMT3A is a writer and TET2 an eraser, then MBD2 is a reader that interprets what is written. Deleterious variants in this 'reader' increase mutation burden just as somatic mutations in the 'writer' or 'eraser' do.
The idea that neutral 'passenger' mutations can serve as clocks ticking out the age of a clone echoes the concept of molecular clocks from Greg Egan's novel Permutation City, where cell age is determined by the accumulation of random changes.
Not published on arXiv. Here are its page, the PDF and the formalization: you can check it yourself, not only read our account.